Andrey Mladentsev
Berater bei V12 Venture Israel MC Ltd.
Profil
Healthcare professional.
Former VP CIS & Baltics at Stada, CEO at Promomed, CEO at NizhPharm (acquired by Stada), CEO at OBL Pharm (acquired by AFK Sistema).
Aktive Positionen von Andrey Mladentsev
Unternehmen | Position | Beginn |
---|---|---|
V12 Venture Israel MC Ltd.
V12 Venture Israel MC Ltd. Investment ManagersFinance V12 Venture Israel MC Ltd (V12 Venture Israel) is a venture capital firm founded in 2020. The firm is headquartered in Tel Aviv, Israel. | Berater | - |
Ehemalige bekannte Positionen von Andrey Mladentsev
Unternehmen | Position | Ende |
---|---|---|
STADA ARZNEIMITTEL | Private Equity Investor | 01.03.2007 |
Ausbildung von Andrey Mladentsev
IEDC Bled School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
V12 Venture Israel MC Ltd.
V12 Venture Israel MC Ltd. Investment ManagersFinance V12 Venture Israel MC Ltd (V12 Venture Israel) is a venture capital firm founded in 2020. The firm is headquartered in Tel Aviv, Israel. | Finance |
STADA Arzneimittel AG
STADA Arzneimittel AG Pharmaceuticals: OtherHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |